News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why Everyone Has A Stake In The Chimerix, Inc. (CMRX) Drug Offered To Dying Boy


3/13/2014 8:16:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A small biotechnology company agreed yesterday to provide their experimental, antiviral drug for the treatment of a seven-year-old Virginia boy, Joshua Hardy, who is currently suffering from a life-threatening adenovirus infection acquired during his cancer treatment at St. Jude Children’s Hospital.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES